QLT receives two fast track designations for degenerative eye disease drug

QLT (TSE:QLT) (NASDAQ:QLTI) announced Wednesday it received two fast track designations from the U.S. FDA

Read more »

Bacterin Receives $15 Million Credit Facility

Bacterin International Holdings (AMEX:BONE) announced Tuesday it secured a 42 month-long, $15 million credit facility with MidCap Financial LLC and Silicon Valley Bank.

Read more »

IntelliCell BioSciences To Open Adipose Tissue Processing Center in Houston

IntelliCell BioSciences, Inc. (OTCQB: SVFC), maker of stromal vascular fraction that contains adipose derived adult stem cells opens new processing center in Houston, Texas.

Read more »

Inovio yields long-term immune responses from cervical cancer vaccine

Inovio Pharmaceuticals reported Friday the positive long-term effects of its VGX-3100 vaccine, designed to treat cervical dysplasia and cancer caused by the human papillomavirus, or HPV.

Read more »

Inherent value to be “developed and extracted” at Amphion

Amphion Innovations (LON:AMP) said it believes there is “significant inherent value to be developed and extracted” from its partner companies, […]

Read more »

ImmunoCellular Therapeutics Expands Phase 2 Trial For Brain Cancer Treatment

ImmunoCellular Therapeutics has expanded the number of sites for its phase two clinical trial ofa potential vaccine treatment for brain cancer.

Read more »

OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug

OXiGENE shares rose in pre-market trading Monday

Read more »

Emergent BioSolutions Acquires Rights To Lymphoma Drug

Emergent BioSolutions has acquired the rights to Zanolimumab, an investigational and late-stage antibody cancer therapy.

Read more »

NeoStem To Drive Shareholder Value, Says Rodman & Renshaw

NeoStem said Thursday that equity research firm Rodman & Renshaw re-iterated the multi-faceted stem cell company’s market outperform rating, based on “multiple milestones to drive shareholder value”.

Read more »

Renovo Actively Progressing With Plans To Maximize Returns After Juvista Failure

Renovo Group (LON:RNVO) confirmed today it will be left with £33 million if it presses ahead with plans to reduce its headcount by 100.

Read more »